From November 17th to 20th, 2025, Wuhan Shengzhiyuan, as an innovative national high-tech enterprise in the field of in vitro diagnostics in China, sincerely invites you to visit our booth: Hall3 H3B36 to explore the cutting-edge development of precision diagnostic technology together.
Since its establishment in 2007, we have been deeply engaged in the medical and health industry for 18 years, always with the mission of “serving a healthy life with biotechnology”. Relying on the quality assurance of ISO 13485 quality management system certification and CE certification, our solutions have served medical institutions in more than 20 countries and regions around the world. At the exhibition site, we will showcase our core achievements The detection items cover applicable scenarios such as infectious diseases (Flu A/B), glucose metabolism (HbA1C), inflammatory items (CRP), cardiac markers (NT-ProBNP), and cancer screening (TK1). At the same time, three dry fluorescence immunoanalyzers, namely FIC-H0 compact, SZY-H01 handheld, and SZY-1100, were exhibited. With dry fluorescence immunoassay technology at its core, it provides stable support for precise diagnosis in multiple scenarios. We always take technological innovation as the driving force, committed to promoting the progress of the medical and health industry, and providing high-quality precision diagnostic solutions for global customers.
Post time: Nov-10-2025